|Bid||43.58 x 800|
|Ask||43.71 x 800|
|Day's Range||43.21 - 44.64|
|52 Week Range||28.03 - 48.50|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.00|
Strong sales of Orthofix's (OFIX) M6-C artificial disc and FITBONE lengthening nail drive its Q1 top line.
Joining me on the call today are our President and Chief Executive Officer, Jon Serbousek; and Chief Financial Officer, Doug Rice. During this call, we will be making forward-looking statements that involve risks and uncertainties.
Orthofix (OFIX) delivered earnings and revenue surprises of 142.86% and 10.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?